Items where Author is "Radue, E. W."

2016

Disanto, G. and Benkert, P. and Lorscheider, J. and Mueller, S. and Vehoff, J. and Zecca, C. and Ramseier, S. and Achtnichts, L. and Findling, O. and Nedeltchev, K. and Radue, E. W. and Sprenger, T. and Stippich, C. and Derfuss, T. and Louvion, J. F. and Kamm, C. P. and Mattle, H. P. and Lotter, C. and Du Pasquier, R. and Schluep, M. and Pot, C. and Lalive, P. H. and Yaldizli, O. and Gobbi, C. and Kappos, L. and Kuhle, J. and Smsc Scientific Board, . (2016) The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS One, 11 (3). e0152347.

2015

Schmidt, A. and Denier, N. and Magon, S. and Radue, E. W. and Huber, C. G. and Riecher-Rössler, A. and Wiesbeck, G. A. and Lang, U. E. and Borgwardt, S. and Walter, M.. (2015) Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution. Translational Psychiatry, 5. e533.

2014

Papadopoulou, A. and Menegola, M. and Kuhle, J. and Ramagopalan, S. V. and D'Souza, M. and Sprenger, T. and Radue, E. W. and Kappos, L. and Yaldizli, O.. (2014) Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 20 (3). pp. 322-330.

2013

Weier, K. and Pezold, S. and Andelova, M. and Amann, M. and Magon, S. and Naegelin, Y. and Radue, E. W. and Stippich, C. and Gass, A. and Kappos, L. and Cattin, Ph. and Sprenger, T.. (2013) Both spinal cord volume and spinal cord lesions impact physical disability in multiple sclerosis. Multiple Sclerosis Journal, 19 (11_suppl). pp. 188-189.

2012

Weier, K. and Beck, A. and Magon, S. and Amann, M. and Naegelin, Y. and Penner, I. K. and Thurling, M. and Aurich, V. and Derfuss, T. and Radue, E. W. and Stippich, C. and Kappos, L. and Timmann, D. and Sprenger, T.. (2012) Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis. Journal of neurology, Vol. 259, H. 12. pp. 2673-2680.

December 2011

Kuhle, Jens and Gosert, Rainer and Buhler, R. and Derfuss, Tobias and Sutter, R and Yaldizli, Ozgür and Radue, E. W. and Ryschkewitsch, C. and Major, E. O. and Kappos, Ludwig and Frank, Stephan and Hirsch, Hans H.. (2011) Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology, 77 (23). pp. 2010-2016.

2011

Sombekke, M. H. and Jafari, N. and Bendfeldt, K. and Mueller-Lenke, N. and Radue, E. W. and Naegelin, Y. and Kappos, L. and Matthews, P. M. and Polman, C. H. and Barkhof, F. and Hintzen, R. and Geurts, J. J. G.. (2011) No influence of KIF1B on neurodegenerative markers in multiple sclerosis. Neurology, Vol. 76, H. 21. pp. 1843-1845.

2010

Bendfeldt, K. and Kappos, L. and Radue, E. W. and Borgwardt, S.. (2010) Longitudinal spatiotemporal distribution of gray and white matter pathology in multiple sclerosis. American journal of neuroradiology, Vol. 31, H. 5 , E45.

Smieskova, R. and Fusar-Poli, P. and Allen, P. and Bendfeldt, K. and Stieglitz, R. D. and Drewe, J. and Radue, E. W. and McGuire, P. K. and Riecher-Rössler, A. and Borgwardt, S. J.. (2010) Neuroimaging predictors of transition to psychosis : a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 34 (8). pp. 1207-1222.

2009

Baranzini, S. E. and Wang, J. and Gibson, R. A. and Galwey, N. and Naegelin, Y. and Barkhof, F. and Radue, E. W. and Lindberg, R. L. and Uitdehaag, B. M. and Johnson, M. R. and Angelakopoulou, A. and Hall, L. and Richardson, J. C. and Prinjha, R. K. and Gass, A. and Geurts, J. J. and Kragt, J. and Sombekke, M. and Vrenken, H. and Qualley, P. and Lincoln, R. R. and Gomez, R. and Caillier, S. J. and George, M. F. and Mousavi, H. and Guerrero, R. and Okuda, D. T. and Cree, B. A. and Green, A. J. and Waubant, E. and Goodin, D. S. and Pelletier, D. and Matthews, P. M. and Hauser, S. L. and Kappos, L. and Polman, C. H. and Oksenberg, J. R.. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human molecular genetics, Vol. 18. pp. 767-778.

O'Connor, P. and Comi, G. and Montalban, X. and Antel, J. and Radue, E. W. and de Vera, A. and Pohlmann, H. and Kappos, L.. (2009) Oral fingolimod (FTY720) in multiple sclerosis : two-year results of a phase II extension study. Neurology : journal of the American Academy of Neurology, Vol. 72. pp. 73-79.

Bendfeldt, K. and Radue, E. W. and Borgwardt, S. J. and Kappos, L.. (2009) Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis. Journal of the neurological sciences, Vol. 285, No. 1-2 , S. 268-269 ; author reply 269.

Smieskova, R. and Fusar-Poli, P. and Allen, P. and Bendfeldt, K. and Stieglitz, R. D. and Drewe, J. and Radue, E. W. and McGuire, P. K. and Riecher-Rössler, A. and Borgwardt, S. J.. (2009) The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? - A Systematic Review. Current Pharmaceutical Design, 15 (22). pp. 2535-2549.

2008

Borgwardt, S. J. and McGuire, P. and Fusar-Poli, P. and Radue, E. W. and Riecher-Rössler, A.. (2008) Anterior cingulate pathology in the prodromal stage of schizophrenia. NeuroImage, Vol. 39. pp. 553-554.

Borgwardt, S. J. and Fusar-Poli, P. and Radue, E. W. and Riecher-Rössler, A.. (2008) Insular pathology in the at-risk mental state. European archives of psychiatry and clinical neuroscience, Vol. 258, H. 4. pp. 254-255.

Haller, S. and Fasler, D. and Ohlendorf, S. and Radue, E. W. and Greenlee, M. W.. (2008) Neural activation associated with corrective saccades during tasks with fixation, pursuit and saccades. Experimental brain research, Vol. 184. pp. 83-94.

Weier, K. and Naegelin, Y. and Thoeni, A. and Hirsch, J. G. and Kappos, L. and Steinbrich, W. and Radue, E. W. and Gass, A.. (2008) Non-communicating syringomyelia : a feature of spinal cord involvement in multiple sclerosis. Brain, Vol. 131, H. 7. pp. 1776-1782.

Garren, H. and Robinson, W. H. and Krasulova, E. and Havrdova, E. and Nadj, C. and Selmaj, K. and Losy, J. and Nadj, I. and Radue, E. W. and Kidd, B. A. and Gianettoni, J. and Tersini, K. and Utz, P. J. and Valone, F. and Steinman, L.. (2008) Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Annals of neurology, Vol. 63, H. 5. pp. 611-620.

Borgwardt, S. J. and McGuire, P. K. and Aston, J. and Gschwandtner, U. and Pflüger, M. O. and Stieglitz, R. D. and Radue, E. W. and Riecher-Rössler, A.. (2008) Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophrenia research, Vol. 106. pp. 108-114.

Sailer, M. and Fazekas, F. and Gass, A. and Kappos, L. and Radue, E. W. and Rieckmann, P. and Toyka, K. and Wiendl, H. and Bendszus, M.. (2008) [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis]. RÖFO, Vol. 180, H. 11. pp. 994-1001.

2007

Vogt, A. and Kappos, L. and Gschwind, L. and Opwis, K. and Radue, E. W. and Penner, I. K.. (2007) Effects of a new computerised working memory training in patients with multiple sclerosis. Multiple Sclerosis Journal, 13 (2_suppl). S235.

2004

Penner, I. -K. and Hardmeier, M. and Vogt, A. and Stoecklin, M. and Raselli, C. and Opwis, K. and Radue, E. W. and Kappos, L.. (2004) Experimentally induced fatigue in MS patients. Multiple sclerosis, Vol. 10, no. 7032, Suppl. 2 , S126-S127.

2000

Mader, I. and Roser, W. and Kappos, L. and Hagberg, G. and Seelig, J. and Radue, E. W. and Steinbrich, W.. (2000) Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques : absolute metabolic values over 2 years during a clinical pharmacological study. American Journal of Neuroradiology, 21 (7). pp. 1220-1227.

1999

Roser, W. and Bubl, R. and Buergin, D. and Seelig, J. and Radue, E. W. and Rost, B.. (1999) Metabolic changes in the brain of patients with anorexia and bulimia nervosa as detected by proton magnetic resonance spectroscopy. International Journal of Eating Disorders, 26 (2). pp. 119-136.

1997

Roser, W. and Hagberg, G. and Mader, I. and Dellas, S. and Seelig, J. and Radue, E. W. and Steinbrich, W.. (1997) Assignment of glial brain tumors in humans by in vivo 1H-magnetic resonance spectroscopy and multidimensional metabolic classification. Magma, Vol. 5, H. 3. pp. 179-183.

1996

Mader, I. and Roser, W. and Hagberg, G. and Schneider, M. and Sauter, R. and Seelig, J. and Radue, E. W. and Steinbrich, W.. (1996) Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. Magma, Vol. 4, H. 2. pp. 139-150.

1995

Hagberg, G. and Burlina, A. P. and Mader, I. and Roser, W. and Radue, E. W. and Seelig, J.. (1995) In vivo proton MR spectroscopy of human gliomas : definition of metabolic coordinates for multi-dimensional classification. Magnetic Resonance in Medicine, 34 (2). pp. 242-252.

Roser, W. and Hagberg, G. and Mader, I. and Brunnschweiler, H. and Radue, E. W. and Seelig, J. and Kappos, L.. (1995) Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magnetic Resonance in Medicine, 33 (6). pp. 811-817.